Archive for the ‘j steroid biochem and molecular biology’ Category
In October, we noted the apparent record holder for longest time between publication and retraction: 25 years, for “Retention of the 4-pro-R hydrogen atom of mevalonate at C-2,2′ of bacterioruberin in Halobacterium halobium,” published in the Biochemical Journal in 1980 and retracted in 2005. (Although an author requested that another 52-year-old paper be retracted, it remains untouched in the literature.)
That record has now been broken. Congratulations to the Journal of Steroid Biochemistry and Molecular Biology and the authors of a December 1985 paper, “Increasing the response rate to cytotoxic chemotherapy by endocrine means.” Here’s the notice, which appears in the January 2013 issue of the journal, making 27 years — and a month, if you’re counting: Read the rest of this entry »
“Clare Francis,” a prolific pseudonymous Retraction Watch tipster, emailed us recently to flag a retraction in the Journal of Steroid Biochemistry and Molecular Biology (JSBMB) of “The anti-inflammatory activity of 1,25-dihydroxyvitamin D3 in macrophages,” a paper by Amos Douvdevani and colleagues at Ben Gurion University in Israel.
Here’s what we found when we clicked on the notice for the 2007 paper, which has been cited 32 times, according to Thomson Scientific’s Web of Knowledge:
This article has been retracted at the request of the authors, in response to concerns raised by the research committee at the authors’ institution. The authors stated the committee had given approval but the committee states no approval was given. The research committee has asked the authors to retract the paper and the authors have agreed.
That sounded odd to us, since it was unclear what approval was needed, or hadn’t been given. Read the rest of this entry »
On second (or third) thought, maybe not: The Journal of Steroid Biochemistry & Molecular Biology has retracted a pair of articles by three Japanese researchers who apparently liked their own work so much they decided to submit it, and submit it—and submit it again.
Here’s the notice for the first paper, a 2004 publication titled “Vitamin D receptor (VDR) promoter targeting through a novel chromatin remodeling complex,” by Shigeaki Kato, Ryoji Fujiki and Hirochika Kitagawa, fairly well-known molecular endocrinologists at the University of Tokyo: Read the rest of this entry »